Platinum-based chemotherapy has long been the standard treatment for metastatic bladder cancer and for muscle-invasive ...

In a clinical trial involving 14 participants, immunotherapy on its own effectively eradicated rectal cancer. This ...

Most bladder cancers start in the inside lining of the bladder. Muscle-invasive bladder cancer (MIBC) is cancer found in the ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

even during cancer treatment. Scientists also revealed that circular fragments of DNA called extrachromosomal DNA (ecDNA) is ...

The risks of adverse effects and complications from treatment for prostate cancer are substantial and continue for years ...

New report outlines long-term risks of prostate cancer treatment, highlighting potential impacts on quality of life and need ...

Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) as a monotherapy for the treatment ...

Researchers examined Medicare claims data for 10 potential complications related to prostate cancer treatment, including erectile dysfunction, incontinence and bladder cancer. Men in the prostate ...

Recent advances in bladder cancer treatments may offer hope of curative care to more patients, including those with high-risk ...

Platinum-based chemotherapy has long been the standard treatment for metastatic bladder cancer and for muscle-invasive bladder cancer where neoadjuvant chemotherapy is delivered prior to surgery.